Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Global Market

0.85USD
14 Dec 2017
Change (% chg)

$-0.05 (-5.53%)
Prev Close
$0.90
Open
$0.90
Day's High
$0.93
Day's Low
$0.85
Volume
26,649
Avg. Vol
26,721
52-wk High
$4.95
52-wk Low
$0.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.280
Jun '17 0.00 -0.197
Mar '17 0.00 -0.199
FY 2016 Dec '16 0.00 -0.170
Sep '16 0.00 -0.194
Jun '16 0.00 -0.162
Mar '16 0.00 -0.235
FY 2015 Dec '15 0.00 -0.173
Sep '15 0.00 -0.085
Jun '15 0.00 -0.394
Mar '15 0.00 -0.635
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 6.65
Earnings (per share)
Quarter Ending Dec-17 1 -0.16 -0.16 -0.16 -0.19
Quarter Ending Mar-18 1 -0.17 -0.17 -0.17 -0.22
Year Ending Dec-17 1 -0.83 -0.83 -0.83 -0.76
Year Ending Dec-18 1 -0.61 -0.61 -0.61 -0.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.13 35.50
P/E High - Last 5 Yrs. 26.83 73.03 45.22
P/E Low - Last 5 Yrs. 26.83 19.69 24.21
Beta 3.26 0.93 0.91
Price to Sales (TTM) -- 5.14 5.89
Price to Book (MRQ) 2.04 3.78 5.66
Price to Tangible Book (MRQ) 2.04 16.48 7.25
Price to Cash Flow (TTM) -- 17.84 24.38
% Owned Institutions 13.11 15.67 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.84 1.49
Dividend Yield - 5 Year Avg -- 0.75 2.05
Dividend 5 Year Growth Rate -- 6.70 5.25
Payout Ratio(TTM) -- 22.03 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.57 6.81
Sales (TTM) vs TTM 1 Yr. Ago -- 4.48 5.59
Sales - 5 Yr. Growth Rate -- 3.27 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.24 32.27 7.98
EPS (TTM) vs TTM 1 Yr. Ago -10.63 -- --
EPS - 5 Yr. Growth Rate -- 3.49 10.93
Capital Spending - 5 Yr. Growth Rate -17.44 11.02 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.74 2.55
Current Ratio (MRQ) 5.04 2.24 3.57
LT Debt to Equity (MRQ) 3.62 35.20 13.37
Total Debt to Equity (MRQ) 6.74 46.13 19.35
Interest Coverage (TTM) -90.68 24.28 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.04 54.91
Gross Margin - 5 Yr. Avg. -- 54.33 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 15.54 15.51
Operating Margin (TTM) -- 5.61 6.68
Operating Margin - 5 Yr. Avg. -- 7.73 10.99
Pre-Tax Margin (TTM) -- 6.59 7.52
Pre-Tax Margin - 5 Yr. Avg. -- 6.97 11.40
Net Profit Margin (TTM) -- 4.64 3.74
Net Profit Margin - 5 Yr. Avg. -- 4.74 7.69
Effective Tax Rate (TTM) -- 21.87 24.27
Effective Tax Rate - 5 Yr. Avg. -- 21.43 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 17,334,783 851,754,569
Net Income/Employee (TTM) -743,649 1,459,291 99,535,212
Receivable Turnover (TTM) -- 5.22 6.13
Inventory Turnover (TTM) -- 4.11 3.55
Asset Turnover (TTM) 0.00 0.83 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.76 2.10 11.32
Return on Assets - 5 Yr. Avg. -118.83 4.82 12.28
Return on Investment (TTM) -112.30 10.01 14.44
Return on Investment - 5 Yr. Avg. -273.41 6.63 16.08
Return on Equity (TTM) -116.86 15.22 16.05
Return on Equity - 5 Yr. Avg. -337.83 10.14 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.11%
# of Holders: 63
Total Shares Held: 4,490,034
3 Mo. Net Change: -1,509,481
# New Positions: 9
# Closed Positions: 15
# Increased Positions: 20
# Reduced Positions: 31
# Net Buyers: -11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.